XOMA Corporation (XOMA) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
pascwaly4 pascwaly4 11/11/2015 3 months $1.46 $0.77 -47.47% -47 Ended
Comments: Undervalued, filings indicate takeover to happen soon
lanai lanai 10/27/2015 1 day $1.31 $1.31 no change 0 Ended
Market $amurai Market $amurai 10/07/2015 1 month $0.94 $1.23 +30.88% 30 Ended
Comments: 37 million dollar deal
Jammin Jammin 09/30/2015 3 months $0.74 $1.38 +86.06% 86 Ended
Antonio Santos Antonio Santos 08/03/2015 3 months $0.75 $1.22 +62.08% 62 Ended
James W. Voss James W. Voss 12/03/2014 3 months $4.86 $3.74 -23% -23 Ended
amazinite amazinite 03/05/2014 3 months $6.82 $4.05 -40.62% -40 Ended
Comments: Exaggerated Correction.
B1capital B1capital 10/01/2013 3 months $4.98 $6.91 +38.76% 38 Ended
khalid obeid khalid obeid 12/31/2010 1 Year $5.24 $3.53 -32.63% -32 Ended
Comments: Industry sector growing or poised for growth
Bing_1 Bing_1 08/03/2010 3 months N/A Ended
Monica_3 Monica_3 05/25/2010 3 months N/A Ended
Comments: excelente
MoMoney_1 MoMoney_1 02/23/2010 3 months N/A Ended
yumatiger yumatiger 02/09/2010 3 months N/A Ended
mbmalone mbmalone 02/01/2010 3 months N/A Ended
Comments: It is the innovation that will provide the drugs we have out there in the future. XOMA has specialty phage display libraries they use to create and manufacture human antibodies. it's a buyout target.
Nasdaqczar Nasdaqczar 01/26/2010 3 months N/A Ended
Comments: Xoma is a winner. XOMA owns key antibody patents and has a strong product pipeline. XOMA is worth North of $5 a share.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.